From the composition recognized
Pharmacological Group
There is no detailed description.
Used in the treatment
- T14.1 Open wound of unspecified body region
- N73.9 Female pelvic inflammatory disease, unspecified
- N41 Inflammatory diseases of prostate
- N39.0 Urinary tract infection, site not specified
- J98.8 Other specified respiratory disorders
- J11 Influenza, virus not identified
- J06 Acute upper respiratory infections of multiple and unspecified sites
- D84.9 Immunodeficiency, unspecified